Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation
Status:
Terminated
Trial end date:
2013-06-03
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe and North America. The aim of this trial is to investigate
if liraglutide treatment can increase the proportion of insulin-independent subjects one year
after islet cell transplantation who required only one (single-donor) islet cell transplant.